General paperThe interactions of typical and atypical antipsychotics with the (−)2,5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus
References (44)
- et al.
Simultaneous quantitation of loxapine, amoxapine, and their 7- and 8-hydroxy metabolites in plasma by high-performance liquid chromatography
J. Chromatogr.
(1991) - et al.
3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites
Eur. J. Pharmac.
(1979) - et al.
Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment
Eur. J. Pharmac.
(1989) Dopamine and the pharmacology of schizophrenia: the state of the evidence
J. Psychiatr. Res.
(1974)- et al.
Interactions of clozapine with the stimulus effects of DOM and LSD
Pharmac. Biochem. Behav.
(1994) - et al.
Occupancy of central neurotransmitter receptors by risperidone, clozapine, and haloperidol, measured ex vivo by quantitative autoradiography
Brain Res.
(1993) - et al.
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the atypical antipsychotics, clozapine and risperidone
Eur. J. Pharmac.
(1994) - et al.
Neuroleptic-induced extrapyramidal side effects: Clinical perspectives with ritanserin (R55 667), a new selective 5-HT2 receptor blocking agent
Clin. Ther. Res.
(1986) - et al.
Efficacy of loxapine in the treatment of paranoid schizophrenia
Psychopharmacology
(1977) - et al.
Clinical overview of risperidone
Effect of chlorpromazine and haloperidol on formation of 3-methoxytryptamine and normetanephrine in mouse brain
Acta Pharmac. Toxic.
(1963)
Neuroleptic side effects: acute extrapyramidal symptoms and tardive dyskinesia
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicenter double-blind comparative study
Acta Psychiatr. Scand.
(1992)
Positron emission tomographic analysis of central D1 and D2 receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
Arch. Gen. Psychiat.
(1992)
The time dependent stimulus effects of (−)2,5- dimethoxy-4-methylamphetamine: Implications for drug- induced stimulus control as a method for the study of hallucinogenic drugs
Psychopharmacology
(1995)
The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis
Psychopharmacology
(1995)
The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: Reassessment of LSD false positives
Psychopharmacology
(1995)
5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine
Psychopharmacology
(1995)
Clozapine blocks the disruptive and discriminative effects of quipazine
Eur. J. Pharmac.
(1985)
Serotonin-S2 blockers in the treatment of chronic schizophrenia
Clin. Neuropharmac.
(1986)
Loxapine: a review of its pharmacological properties and therapeutic efficacy as a antipsychotic agent
Drugs
(1978)
Antagonism of the l-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist
J. Med. Chem.
(1993)
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.